ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

MEDS vs ESYN // FREE CASH FLOW YIELD

DataMeds AI Inc. (NASDAQ) VS. EnerSyn Global Inc. (NASDAQ) • 15-METRIC TALLY: MEDS 1 — ESYN 4
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MEDS VS. ESYN) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC MEDS ESYN SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin -27.50% 53.00% -80.50 ESYN /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield ACTIVE — -3.25% — TIE /fcf-yield <GO>
Operating Margin -60.00% — — TIE /operating-margins <GO>
Net Profit Margin -60.00% -60.00% 0.00 TIE /net-margins <GO>
Revenue Growth (YoY) 28.70% -30.80% +59.50 MEDS /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 4/9 -2.00 ESYN /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 41.1 46.4 -5.30 ESYN /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $9.8M $54.4M -$44.6M ESYN /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR MEDS REV ESYN REV MEDS GROSS % ESYN GROSS % MEDS FCF ESYN FCF
FY 2025 $23.3M $866.9K -27.5% 53.0% -$10.9M -$1.8M
FY 2024 $18.1M $1.3M 9.7% 48.0% -$1.2M -$1.8M
FY 2023 $0 $1.2K — — -$349.1K -$2.6M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MEDS // BETA —
ESYN // BETA —